HHS cancels data collection deadline scheduled for today to inform remdesivir distribution

May 18, 2020 - 02:53 PM
hhs-health-and-human-services-seal

The Department of Health and Human Services has canceled today’s deadline for hospitals and health systems to submit data to inform the agency’s distribution of its supply of remdesivir. The deadline for submitting data into HHS’s TeleTracking system was supposed to be at 11:59 p.m. ET today.

Late last week, HHS notified hospitals that another round of data were to be collected by midnight tonight to inform the distribution of the remdesivir that Gilead donated to the U.S. Over the weekend, HHS determined that it did not need the additional data at this time. Registered users of the TeleTracking portal received an email announcing the agency’s decision to postpone data collection.

While hospitals do not have to submit the COVID-19 admission and COVID-19 intensive care unit occupancy data to TeleTracking today, HHS has indicated it intends to ask for updated data again in the next few weeks.

The AHA has urged HHS to share a data reporting schedule with hospitals so that their teams know well in advance when the data are due and plan to fulfill the request. 

Related News Articles

Headline
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
CDC: COVID-19 surging across the U.S.
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
CDC issues advisory on increased parvovirus B19 cases in the U.S. 
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Blog
RAND 5.0 – The Health Policy Equivalent of Groundhog Day
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
NASEM releases evidence review on COVID-19 vaccine safety
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…